Transient parkinsonism: Induced by progesterone or pregnancy?

Movement Disorders

Volumn 19, Issue 11, 2004, Pages 1382-1384

  Demirkiran, Meltem ^a   Aslan, Kezban ^a   Bicakci, Sebnem ^a   Bozdemir, Hacer ^a   Özeren, Ali ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Drug induced parkinsonism; Estrogen; Neurosteroids; Parkinsonism; Pregnancy; Progesterone

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ABORTION; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CURETTAGE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FAMILY HISTORY; FEMALE; FETUS DEATH; HUMAN; LABORATORY TEST; NEUROLOGIC EXAMINATION; OUTCOMES RESEARCH; PARKINSONISM; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ABORTION, THREATENED; ADULT; BRAIN ISCHEMIA; DELAYED-ACTION PREPARATIONS; DILATATION AND CURETTAGE; DOMINANCE, CEREBRAL; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; HYDROXYPROGESTERONES; MAGNETIC RESONANCE IMAGING; PARKINSONIAN DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; REMISSION, SPONTANEOUS; TOCOLYTIC AGENTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 8844285227     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20222     Document Type: Article

References (22)

1. Jankovic J, Tolosa. Parkinson's disease and movement disorders, 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2002. p 73-89.
2. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 2001;22:45-46.
3. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003;20:1309-1319.
4. Ugwumadu AH. Bacterial vaginosis in pregnancy. Curr Opin Obstet Gynecol 2002;14:115-118.
5. Gaillard PJ, de Boer AB, Bremier DD. Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro. Microvasc, Res 2003;65:24-31.
6. Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res 2002;133:27-35.
7. Ling ZD, Gayle DA, Yong Ma S, Lipton JW, Tong CW, Hong JS, Carvey PM. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 2002;17:116-124.
8. Carvey PM, Chang Q, Lipton JW, Ling Z. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front Biosci 2003;8:826-837.
9. Hagell P, Odin P, Vinge E. Pregnancy in Parkinson's disease: a review of the literature and a case report. Mov Disord 1998;13: 34-38.
10. Shulman LM, Minagar A, Weiner W. The effect of pregnancy in Parkinson's disease. Mov Disord 2000;15:132-135.
11. Benito-Leon J, Bermejo F, Porta-Etessam J. Pregnancy in Parkinson's disease: a review of the literature and a case report. Mov Disord 1999;14:194.
12. Tsang KL, Jiang H, Ramsden DB, Ho SL. The use of estrogen in the treatment of Parkinson's disease. Parkinsonism Relat Disord 2001;8:133-137.
13. Quinn NP, Marsden CD. Menstrual-related fluctuations in Parkinson's disease. Mov Disord 1986;1:85-87.
14. Saunders-Pullman R, Gordon-Elliot J, Parides M, Fahn S, Saunders HR, Bressman S. The effect of estrogen replacement therapy on early Parkinson's disease. Neurology 1999;52:1417-1421.
15. Tsang KL, Ho SL, Lo SK. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 2000;54:2292-2298.
16. Kompoliti K. Estrogen and movement disorders. Clin Neuropharmacol 1999;22:318-326.
17. Morissette M., Paola DT. Effect of chronic estradiol and progesterone, treatments of ovariectomized rats on brain dopamine uptake sites. J Neurochem 1993;60:1876-1881.
18. Strijks E., Kremer MAJ, Horstink M. Effects of female sex steroids on Parkinson's disease in postmenopausal women. Clin Neuropharmacol 1999;22:93-97.
19. Cabrera RJ, Navarro CE. Progesterone in vitro increases NMDA-evoked [3H] dopamine release from striatal slices in proestrus rats. Neuropharmacology 1996;35:175-178.
20. Nuwayhid SJ, Werling LL. Steroids modulate N methyl-D-aspartate-stimulated [3H] dopamine release from rat striatum via sigma receptors. J Pharmacol Exp Ther 2003;306:934-940.
21. Cabrera RJ, Bregonzio C, Lanconi M, Mampel A. Allopregnanolone increase in striatal N-methyl-D-aspartic acid evoked [3H] dopamine release is estrogen and progesterone dependent. Cell Mol Neurobiol 2002;22:445-454.
22. Di Michele F, Longone P, Romeo E, Lucchetti S, Brusa L, Pierantozzi M, Bassi A, Bernardi G, Stanzione P. Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease. Neurol Sci 2003;24:172-173.